In the first half of 2024, it seemed Eli Lilly (NYSE: LLY) could do no wrong. Is Eli Lilly a good stock to buy on the dip? On Jan. 14, CEO David Ricks told investors that 2024 sales would come in at ...
The colorant was banned from cosmetics and non-oral medications years ago because a study showed it caused cancer in rats. But it remained approved for many snack foods and other products until this ...
Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4.
Jubilant Pharmova said that the solid oral formulations facility of its subsidiary Jubilant Cadista Pharmaceuticals Inc., which is located at Salisbury, Maryland, USA, has received five observations ...